Alnylam Pharmaceuticals develops novel therapeutics-based RNAi and provides overviews of recent drug development programs. read more

EMPLOYEE PARTICIPANTS: 23

TOTAL RATINGS: 213

CEO: John Maraganore

Alnylam Pharmaceuticals CEO & Leadership Team Ratings

John Maraganore and the Alnylam Pharmaceuticals leadership team are scored a "B-" by 17 employees placing it in the Top 40% of companies sized 201-500 Employees on Comparably. The Leadership Score of 71/100 is based on 42 ratings; it combines employee feedback on their CEO (78/100), Manager (59/100), and Executive Team (73/100).

John Maraganore Alnylam Pharmaceuticals CEO Rating

Top 10% Compared to other companies of similar size in Boston

78 / 100

John Maraganore the CEO of Alnylam Pharmaceuticals received an average score of 78 from Alnylam Pharmaceuticals employees.

Caucasian employees at Alnylam Pharmaceuticals rate the CEO the highest.

Caucasian: 87

Alnylam Pharmaceuticals Manager Rating

Bottom 20% Compared to other companies of similar size in Boston

59 / 100

Managers received an average score of 59 from Alnylam Pharmaceuticals employees.

Caucasian employees at Alnylam Pharmaceuticals rate their Manager the highest.

Caucasian: 58

Alnylam Pharmaceuticals Executive Team Rating

Top 30% Compared to other companies of similar size in Boston

73 / 100

The Executive team received an average score of 73 from Alnylam Pharmaceuticals employees.

Rate your company